141
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art

ORCID Icon, ORCID Icon, &
Pages 196-203 | Received 31 Jan 2021, Accepted 22 Mar 2021, Published online: 08 Apr 2021

References

  • Otto CM, Nishimura RA, Bonow RO, et al. ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American Heart Association/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e72–e227.
  • Morís C, Pascual I, Avanzas P. Will TAVI Be the Standard of Care in the Treatment of Aortic Stenosis?. Revista Española De Cardiología (English Edition). 2016;69(12):1131–1134. DOI:https://doi.org/10.1016/j.rec.2016.09.012.
  • Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–1331.
  • Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620.
  • Eggebrecht H, Schmermund A, Voigtlander T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8(1):129–138.
  • Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121(7):870–878.
  • Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34(5):1126–1129.
  • Schmidt T, Akdag O, Wohlmuth P, et al. Histological findings and predictors of cerebral debris from transcatheter aortic valve replacement: the ALSTER experience. JAHA. 2016;5(11):e004399. DOI:https://doi.org/10.1161/JAHA.116.004399.
  • Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36(31):2070–2078.
  • Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA. 2016;316(6):592–601.
  • Van Mieghem NM, van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. 2016;12(4):499–507.
  • Rodes-Cabau J, Kahlert P, Neumann FJ, et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interv. 2014;7(10):1146–1155.
  • Baumbach A, Mullen M, Brickman AM, Aggarwal SK, et al. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention. 2015;11(1):75–84.
  • Naber CK, Ghanem A, Abizaid AA, Wolf A, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8(1):43–50.
  • Giustino G, Mehran R, Veltkamp R, et al. Neurological outcomes with embolic protection devices in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2016;9(20):2124–2133.
  • Abdul-Jawad Altisent O, Puri R, Rodés-Cabau J. Embolic protection devices during TAVI: current evidence and uncertainties. Rev Esp Cardiol (Engl Ed). 2016;69(10):962–972.
  • Samim M, Agostoni P, Hendrikse J, et al. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2015;149(3):799–805.e2.
  • Kapadia SR, Kodali S, Makkar R, Mehran R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017;69(4):367–377.
  • Latib A, Pagnesi M. Cerebral embolic protection during transcatheter aortic valve replacement: a disconnect between logic and data? J Am Coll Cardiol. 2017;69(4):378–380.
  • Arnold M, Schulz-Heise S, Achenbach S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv. 2010;3(11):1126–1132.
  • Samim M, Hendrikse J, van der Worp HB, et al. Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors. Clin Res Cardiol. 2015;104(5):430–438.
  • Seeger J, Gonska B, Otto M, et al. Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures. JACC Cardiovasc Interv. 2017;10(22):2297–2303.
  • Seeger J, Kapadia SR, Kodali S, et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Eur Heart J. 2019;40(17):1334–1340.
  • Samim M, van der Worp B, Agostoni P, et al. TriGuard™ HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2017;89(3):470–477.
  • Vlastra W, Vendrik J, Koch KT, et al. Cerebral protection devices during transcatheter aortic valve implantation. Trends Cardiovasc Med. 2018;28(6):412–418.
  • Pagnesi M, Martino EA, Chiarito M, et al. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and meta-analysis. Int J Cardiol. 2016;221:97–106.
  • Giustino G, Sorrentino S, Mehran R, et al. Cerebral embolic protection during TAVR: a clinical event meta-analysis. J Am Coll Cardiol. 2017;69(4):465–466.
  • Van Gils L, Kroon H, Daemen J, et al. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2018;91(4):790–797.
  • Bagur R, Rodes-Cabau J, Doyle D, et al. Transcatheter aortic valve implantation with "no touch" of the aortic arch for the treatment of severe aortic stenosis associated with complex aortic atherosclerosis. J Card Surg. 2010;25(5):501–503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.